Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2006 1
2007 3
2008 1
2009 3
2010 2
2012 3
2013 6
2014 4
2015 12
2016 11
2017 9
2018 15
2019 13
2020 29
2021 21
2022 17
Text availability
Article attribute
Article type
Publication date

Search Results

132 results
Results by year
Filters applied: . Clear all
Page 1
Ceftazidime-Avibactam Use for Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae Infections: A Retrospective Observational Multicenter Study.
Tumbarello M, Raffaelli F, Giannella M, Mantengoli E, Mularoni A, Venditti M, De Rosa FG, Sarmati L, Bassetti M, Brindicci G, Rossi M, Luzzati R, Grossi PA, Corona A, Capone A, Falcone M, Mussini C, Trecarichi EM, Cascio A, Guffanti E, Russo A, De Pascale G, Tascini C, Gentile I, Losito AR, Bussini L, Corti G, Ceccarelli G, Corcione S, Compagno M, Giacobbe DR, Saracino A, Fantoni M, Antinori S, Peghin M, Bonfanti P, Oliva A, De Gasperi A, Tiseo G, Rovelli C, Meschiari M, Shbaklo N, Spanu T, Cauda R, Viale P. Tumbarello M, et al. Among authors: luzzati r. Clin Infect Dis. 2021 Nov 2;73(9):1664-1676. doi: 10.1093/cid/ciab176. Clin Infect Dis. 2021. PMID: 33618353 Free article.
Mycobacterium chimaera infections: An update.
Riccardi N, Monticelli J, Antonello RM, Luzzati R, Gabrielli M, Ferrarese M, Codecasa L, Di Bella S, Giacobbe DR. Riccardi N, et al. Among authors: luzzati r. J Infect Chemother. 2020 Mar;26(3):199-205. doi: 10.1016/j.jiac.2019.11.004. Epub 2019 Dec 13. J Infect Chemother. 2020. PMID: 31843377 Review.
Resistance to ceftazidime/avibactam in infections and colonisations by KPC-producing Enterobacterales: a systematic review of observational clinical studies.
Di Bella S, Giacobbe DR, Maraolo AE, Viaggi V, Luzzati R, Bassetti M, Luzzaro F, Principe L. Di Bella S, et al. Among authors: luzzati r. J Glob Antimicrob Resist. 2021 Jun;25:268-281. doi: 10.1016/j.jgar.2021.04.001. Epub 2021 Apr 23. J Glob Antimicrob Resist. 2021. PMID: 33895414 Free article. Review.
Profiling of Oral Microbiota and Cytokines in COVID-19 Patients.
Iebba V, Zanotta N, Campisciano G, Zerbato V, Di Bella S, Cason C, Luzzati R, Confalonieri M, Palamara AT, Comar M. Iebba V, et al. Among authors: luzzati r. Front Microbiol. 2021 Jul 30;12:671813. doi: 10.3389/fmicb.2021.671813. eCollection 2021. Front Microbiol. 2021. PMID: 34394024 Free PMC article.
Community pharmacists' exposure to COVID-19.
Cabas P, Di Bella S, Giuffrè M, Rizzo M, Trombetta C, Luzzati R, Antonello RM, Parenzan K, Liguori G. Cabas P, et al. Among authors: luzzati r. Res Social Adm Pharm. 2021 Jan;17(1):1882-1887. doi: 10.1016/j.sapharm.2020.05.020. Epub 2020 May 27. Res Social Adm Pharm. 2021. PMID: 32499159 Free PMC article.
Aspirin and Infection: A Narrative Review.
Di Bella S, Luzzati R, Principe L, Zerbato V, Meroni E, Giuffrè M, Crocè LS, Merlo M, Perotto M, Dolso E, Maurel C, Lovecchio A, Dal Bo E, Lagatolla C, Marini B, Ippodrino R, Sanson G. Di Bella S, et al. Among authors: luzzati r. Biomedicines. 2022 Jan 25;10(2):263. doi: 10.3390/biomedicines10020263. Biomedicines. 2022. PMID: 35203473 Free PMC article. Review.
Dengue: Status of current and under-development vaccines.
Redoni M, Yacoub S, Rivino L, Giacobbe DR, Luzzati R, Di Bella S. Redoni M, et al. Among authors: luzzati r. Rev Med Virol. 2020 Jul;30(4):e2101. doi: 10.1002/rmv.2101. Epub 2020 Feb 26. Rev Med Virol. 2020. PMID: 32101634 Review.
Time to reconsider moxifloxacin anti-anaerobic activity?
Principe L, Sanson G, Luzzati R, Aschbacher R, Pagani E, Luzzaro F, Di Bella S. Principe L, et al. Among authors: luzzati r. J Chemother. 2022 Aug 10:1-2. doi: 10.1080/1120009X.2022.2106637. Online ahead of print. J Chemother. 2022. PMID: 35947127
132 results